Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

365 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma.
Maruyama D, Tsukasaki K, Uchida T, Maeda Y, Shibayama H, Nagai H, Kurosawa M, Suehiro Y, Hatake K, Ando K, Yoshida I, Hidaka M, Murayama T, Okitsu Y, Tsukamoto N, Taniwaki M, Suzumiya J, Tamura K, Yamauchi T, Ueda R, Tobinai K. Maruyama D, et al. Among authors: suehiro y. Ann Hematol. 2019 Jan;98(1):131-142. doi: 10.1007/s00277-018-3418-2. Epub 2018 Jul 5. Ann Hematol. 2019. PMID: 29974231 Free PMC article. Clinical Trial.
Correction to: Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma.
Maruyama D, Tsukasaki K, Uchida T, Maeda Y, Shibayama H, Nagai H, Kurosawa M, Suehiro Y, Hatake K, Ando K, Yoshida I, Hidaka M, Murayama T, Okitsu Y, Tsukamoto N, Taniwaki M, Suzumiya J, Tamura K, Yamauchi T, Ueda R, Tobinai K. Maruyama D, et al. Among authors: suehiro y. Ann Hematol. 2018 Dec;97(12):2529-2530. doi: 10.1007/s00277-018-3455-x. Ann Hematol. 2018. PMID: 30054705 Free PMC article.
Clinical Features of Systemic Metastatic Retinal Lymphoma in Japanese Patients.
Taki R, Takeda A, Yoshikawa H, Fukuhara T, Arita R, Suehiro Y, Choi I, Kumano Y, Nakamura T, Ishibashi T. Taki R, et al. Among authors: suehiro y. Ocul Immunol Inflamm. 2017 Oct;25(5):654-662. doi: 10.3109/09273948.2016.1151894. Epub 2016 Apr 12. Ocul Immunol Inflamm. 2017. PMID: 27070953
Influence of UGT1A1 polymorphism on etoposide plus platinum-induced neutropenia in Japanese patients with small-cell lung cancer.
Negoro Y, Yano R, Yoshimura M, Suehiro Y, Yamashita S, Kodawara T, Watanabe K, Tsukamoto H, Nakamura T, Kadowaki M, Morikawa M, Umeda Y, Anzai M, Ishizuka T, Goto N. Negoro Y, et al. Among authors: suehiro y. Int J Clin Oncol. 2019 Mar;24(3):256-261. doi: 10.1007/s10147-018-1358-4. Epub 2018 Oct 17. Int J Clin Oncol. 2019. PMID: 30328531
Cronkhite-Canada syndrome associated with schizophrenia.
Nakayama M, Muta H, Somada S, Maeda T, Mutoh T, Shimizu K, Suehiro Y, Hisano T, Kurita R, Shiraishi T, Mori M, Yoshikawa Y, Tsunetomi N, Uchida A, Tani K. Nakayama M, et al. Among authors: suehiro y. Intern Med. 2007;46(4):175-80. doi: 10.2169/internalmedicine.46.1735. Epub 2007 Feb 15. Intern Med. 2007. PMID: 17301512 Free article.
Non-transmissible Sendai virus encoding granulocyte macrophage colony-stimulating factor is a novel and potent vector system for producing autologous tumor vaccines.
Inoue H, Iga M, Nabeta H, Yokoo T, Suehiro Y, Okano S, Inoue M, Kinoh H, Katagiri T, Takayama K, Yonemitsu Y, Hasegawa M, Nakamura Y, Nakanishi Y, Tani K. Inoue H, et al. Among authors: suehiro y. Cancer Sci. 2008 Nov;99(11):2315-26. doi: 10.1111/j.1349-7006.2008.00964.x. Epub 2008 Oct 18. Cancer Sci. 2008. PMID: 18957055 Free article.
[New strategies in anti-tumor immunotherapy].
Iga-Murahashi M, Hijikata Y, Suehiro Y, Inoue H, Tanaka Y, Shimoda S, Marumoto T, Okazai T, Yoshida K, Tsunoda T, Tani K. Iga-Murahashi M, et al. Among authors: suehiro y. Rinsho Ketsueki. 2010 Nov;51(11):1654-60. Rinsho Ketsueki. 2010. PMID: 21157128 Review. Japanese. No abstract available.
Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203.
Watanabe T, Matsuno Y, Wakabayashi M, Maruyama D, Yamamoto K, Kubota N, Shimada K, Asagoe K, Yamaguchi M, Ando K, Ogura M, Kuroda J, Suehiro Y, Tsukasaki K, Tobinai K, Nagai H. Watanabe T, et al. Among authors: suehiro y. Hematol Oncol. 2024 May;42(3):e3272. doi: 10.1002/hon.3272. Hematol Oncol. 2024. PMID: 38595316 Clinical Trial.
365 results